Project Director: Arthur Thuot
Project Coordinators: Mathilde Paquet & Chiraz Bensemmane
Project Publisher: Julie Avena
Graphic Assistance: Christine Guiang
For exclusive interviews and more info, please log onto or write to firstname.lastname@example.org
For every manager with a surefire strategy for China, William Keller has one piece of advice: "Let it go!" Keller should know. He founded Roche's China affiliate in 1994 and built it into a market leader. In the meantime, he became an eminence whose wisdom is sought industry-wide, from his role as spokesman for the Zhangjiang Hi-Tech Park, the world's highest concentration of Life Science companies, to lobbying for Shanghai's successful bid to host the 2010 World Expo. "Don't try to control everything," Keller goes on, "and see what comes out. Some will fail, and some will get very good insights to go further. It's a journey of exploration. Explorers have a different mindset than followers!"
"In China, we do believe the government will have an even bigger role to play, because of the way the country is set up, and because of the stage the industry is evolving through," says Sheryl Jacobson, senior partner in Monitor Group's China Healthcare practice, speaking to the role of innovation in the sector. "We're still at a stage where the MNCs (Multinational Corporation) are USD 1 billion businesses at most, and primarily commercial entities. Local companies are anywhere, in terms of manufacturing revenue, from almost nothing to USD 0.5 billion. The typical company that does innovation from the lab to in-patient trials – the traditional US or European model – simply will not work in China."